
FPL 55712
CAS No. 40785-97-5
FPL 55712( —— )
Catalog No. M33852 CAS No. 40785-97-5
FPL 55712 is a leukotriene receptor and SRS-A antagonist that inhibits bronchoconstriction and can be used in studies of asthma and coronary artery thrombosis.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 131 | Get Quote |
![]() ![]() |
5MG | 188 | Get Quote |
![]() ![]() |
10MG | 282 | Get Quote |
![]() ![]() |
25MG | 477 | Get Quote |
![]() ![]() |
50MG | 680 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameFPL 55712
-
NoteResearch use only, not for human use.
-
Brief DescriptionFPL 55712 is a leukotriene receptor and SRS-A antagonist that inhibits bronchoconstriction and can be used in studies of asthma and coronary artery thrombosis.
-
DescriptionFPL-55712 free base is a leukotriene receptor antagonist. FPL-55712 free base is also an antagonist of slow reacting substance of anaphylaxis (SRS-A). FPL-55712 free base inhibits leukotriene-induced bronchoconstriction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetLTR
-
RecptorLTR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number40785-97-5
-
Formula Weight498.52
-
Molecular FormulaC27H30O9
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)C=1OC=2C(=CC=C(OCC(O)COC3=CC=C(C(=O)C)C(O)=C3CCC)C2CCC)C(=O)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. O'Donnell M, et al. Pharmacologic properties of FPL 55712 administered by aerosol. Agents Actions. 1984 Jan;14(1):43-8.?
molnova catalog



related products
-
Moxilubant HCl
Moxilubant HCl is a small molecule leukotriene B4 receptor 1 (LTB4R) antagonist for the treatment of immune system disorders, skin and musculoskeletal disorders, and may be used in studies of psoriasis and rheumatoid arthritis.
-
FPL 55712
FPL 55712 is a leukotriene receptor and SRS-A antagonist that inhibits bronchoconstriction and can be used in studies of asthma and coronary artery thrombosis.
-
Ubenimex
Bestatin (Ubenimex) is a competitive aminopeptidase inhibitor.